Moreover, a recent annotated lncRNA SAMMSON is regulated by melanocytic-specific transcriptional factor SOX10, and the deficiency of SAMMSON is capable of restraining tumor progression and increasing the efficacy of MAPK-inhibition targeted therapy (109, 117, 118). The gene discussed is SAMMSON; the disease is neoplasm.